Michael A Potter, MD | |
16001 W 9 Mile Rd Ste 601, Southfield, MI 48075-4818 | |
(248) 849-3000 | |
Not Available |
Full Name | Michael A Potter |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 33 Years |
Location | 16001 W 9 Mile Rd Ste 601, Southfield, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205942323 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 4301060521 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Providence Hospital, Southfield And Novi | Southfield, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northland Anesthesia Associates Pc | 5294623336 | 21 |
Providence Park Anesthesia Associates, Pc | 7315009479 | 22 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
Investigators say that deaf children who are given cochlear implants before the age of 30 months are more able to combine what they hear and what they see than those who receive their implants when they are older.
Anyone who has ever been subject to chronic stress knows that it can take a toll on emotions and the ability to think clearly. Now, new research uncovers a neural mechanism that directly links repeated stress with impaired memory.
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.
Many EPA programs make decisions on regulation of metals, particularly controlling releases to the environment and establishing acceptable levels in air, water, or land.
› Verified 8 days ago
Entity Name | Northland Anesthesia Associates Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528001880 PECOS PAC ID: 5294623336 Enrollment ID: O20040309001092 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
Investigators say that deaf children who are given cochlear implants before the age of 30 months are more able to combine what they hear and what they see than those who receive their implants when they are older.
Anyone who has ever been subject to chronic stress knows that it can take a toll on emotions and the ability to think clearly. Now, new research uncovers a neural mechanism that directly links repeated stress with impaired memory.
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.
Many EPA programs make decisions on regulation of metals, particularly controlling releases to the environment and establishing acceptable levels in air, water, or land.
› Verified 8 days ago
Entity Name | Providence Park Anesthesia Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942459672 PECOS PAC ID: 7315009479 Enrollment ID: O20081224000115 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
Investigators say that deaf children who are given cochlear implants before the age of 30 months are more able to combine what they hear and what they see than those who receive their implants when they are older.
Anyone who has ever been subject to chronic stress knows that it can take a toll on emotions and the ability to think clearly. Now, new research uncovers a neural mechanism that directly links repeated stress with impaired memory.
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.
Many EPA programs make decisions on regulation of metals, particularly controlling releases to the environment and establishing acceptable levels in air, water, or land.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Michael A Potter, MD 255 W Michigan Ave, Jackson, MI 49201-2218 Ph: (517) 787-6440 | Michael A Potter, MD 16001 W 9 Mile Rd Ste 601, Southfield, MI 48075-4818 Ph: (248) 849-3000 |
News Archive
Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.
Investigators say that deaf children who are given cochlear implants before the age of 30 months are more able to combine what they hear and what they see than those who receive their implants when they are older.
Anyone who has ever been subject to chronic stress knows that it can take a toll on emotions and the ability to think clearly. Now, new research uncovers a neural mechanism that directly links repeated stress with impaired memory.
Aastrom Biosciences, Inc., the leading developer of autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the company will pursue a Phase 3 clinical program for its autologous cell therapy for the treatment of critical limb ischemia (CLI) through the U.S. Food and Drug Administration's special protocol assessment (SPA) process. Aastrom is currently completing a Phase 2b clinical trial of its cell therapy in patients with CLI and recently met with FDA officials to discuss plans for the Phase 3 program.
Many EPA programs make decisions on regulation of metals, particularly controlling releases to the environment and establishing acceptable levels in air, water, or land.
› Verified 8 days ago
Jonathan Arie Kroll, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Dominick Lago Jr., M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Jeffrey Joseph Kirouac, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 16001 W 9 Mile Rd, Southfield, MI 48075 Phone: 248-849-3000 | |
Leslie A Mumaw, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26051 Lahser Rd, Southfield, MI 48034 Phone: 248-223-9945 | |
Mark Mounayer, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 26025 Lahser Rd Fl 3, Southfield, MI 48033 Phone: 248-663-1900 Fax: 248-663-1901 | |
Dr. Alexander Grossi, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 16000 W 9 Mile Rd, Suite 601, Southfield, MI 48075 Phone: 734-233-8481 | |
Shad Siddiqi, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 22250 Providence Dr Ste 401, Southfield, MI 48075 Phone: 866-974-2673 Fax: 866-939-2673 |